Research ELISA (Enzyme-Linked Immunosorbent Assay)

Research ELISA (Enzyme-Linked Immunosorbent Assay)

Global Research ELISA (Enzyme-Linked Immunosorbent Assay) Market to Reach US$692.3 Million by 2030

The global market for Research ELISA (Enzyme-Linked Immunosorbent Assay) estimated at US$538.2 Million in the year 2023, is expected to reach US$692.3 Million by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. ELISA Kits, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$478.6 Million by the end of the analysis period. Growth in the ELISA Development Sets & Antibody Pairs segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$145.6 Million While China is Forecast to Grow at 6.1% CAGR

The Research ELISA (Enzyme-Linked Immunosorbent Assay) market in the U.S. is estimated at US$145.6 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$140.2 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Research ELISA (Enzyme-Linked Immunosorbent Assay) Market - Key Trends and Drivers Summarized

Enzyme-Linked Immunosorbent Assay (ELISA) is a widely utilized analytical biochemistry assay, designed for detecting and quantifying substances such as peptides, proteins, antibodies, and hormones. This assay leverages the specificity of antibodies to detect the presence of specific biomolecules in complex samples. ELISA operates on the principle of antigen-antibody interactions, where an enzyme-linked antigen or antibody produces a measurable signal, typically a color change, in the presence of its target molecule. This technique has found extensive applications in diagnostics, quality control, and research across various fields including clinical diagnostics, food safety, and environmental monitoring.

ELISA`s robustness and versatility stem from its ability to deliver highly specific and sensitive results, making it indispensable in both clinical and research settings. In clinical diagnostics, ELISA is crucial for disease detection, including viral and bacterial infections, autoimmune diseases, and allergies. For instance, it is commonly used in the detection of HIV, hepatitis, and SARS-CoV-2. In the food industry, ELISA helps ensure food safety by detecting allergens, toxins, and contaminants. Moreover, environmental agencies employ ELISA to monitor pollutants and pathogens in water and soil. The assay`s adaptability is further enhanced by the development of various formats, such as direct, indirect, sandwich, and competitive ELISA, each tailored for specific analytical needs.

The growth in the ELISA market is driven by several factors including advancements in technology, increasing prevalence of chronic and infectious diseases, and the rising demand for cost-effective and reliable diagnostic methods. Technological innovations, such as the development of automated and high-throughput ELISA systems, have significantly improved the efficiency and accuracy of the assays. The surge in chronic diseases like cancer and diabetes, alongside emerging infectious diseases, has amplified the need for precise diagnostic tools, thus boosting the demand for ELISA. Additionally, the growing trend towards personalized medicine and the expanding application of ELISA in drug development and monitoring therapeutic responses have further fueled market growth. The increasing awareness and regulatory emphasis on food and environmental safety also contribute to the expanding ELISA market, as these assays are vital for ensuring compliance with safety standards.

Select Competitors (Total 27 Featured) -

• American Laboratory Products Company (ALPCO) (US)
• BD Biosciences (US)
• BioLegend, Inc. (US)
• Bio-Rad Laboratories, Inc. (US)
• Enzo Life Sciences, Inc. (US)
• Merck KGaA
• Mercodia AB (Sweden)
• R&D Systems, Inc. (US)
• Thermo Fischer Scientific Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.